{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:53Z","timestamp":1792090553245,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.regg.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T20:40:31Z","timestamp":1668717631000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-9969","authenticated-orcid":false,"given":"Javier","family":"Jaramillo-Hidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Quezada-Feijo\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-6265","authenticated-orcid":false,"given":"Javier","family":"G\u00f3mez-Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ayala-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regg.2022.10.005_bib0165","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","author":"Yamamoto","year":"2019","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.regg.2022.10.005_bib0170","first-page":"133","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.regg.2022.10.005_bib0175","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.regg.2022.10.005_bib0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","article-title":"Seven factors predict a delayed diagnosis of cardiac amyloidosis","volume":"25","author":"Bishop","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.regg.2022.10.005_bib0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.regg.2022.10.005_bib0190","first-page":"318","article-title":"Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey","author":"Morgan","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.regg.2022.10.005_bib0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15420\/cfr.2018.22.2","article-title":"Frailty in heart failure: implications for management","volume":"4","author":"Vitale","year":"2018","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.regg.2022.10.005_bib0200","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.archger.2008.09.006","article-title":"The Spanish versions of the Barthel index (BI) and the Katz index (KI) of activities of daily living (ADL): a structured review","volume":"49","author":"Caba\u00f1ero-Mart\u00ednez","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.regg.2022.10.005_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.regg.2022.10.005_bib0210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2190\/UURL-2RYU-WRYD-EY3K","article-title":"A measure of primary sociobiological functions","volume":"6","author":"Katz","year":"1976","journal-title":"Int J Health Serv"},{"key":"10.1016\/j.regg.2022.10.005_bib0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1477-7525-10-130","article-title":"Validation of the Spanish version of the Lawton IADL Scale for its application in elderly people","volume":"10","author":"Vergara","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.regg.2022.10.005_bib0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"10.1016\/j.regg.2022.10.005_bib0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.regg.2022.10.005_bib0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/da.22217","article-title":"Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV","volume":"31","author":"Uher","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.regg.2022.10.005_bib0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.regg.2022.10.005_bib0240","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.regg.2022.10.005_bib0245","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagn\u00f3stico y tratamiento de la amiloidosis cardiaca por transtiretina. Progreso y esperanza","volume":"70","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.regg.2022.10.005_bib0250","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.recesp.2011.12.015","article-title":"Papel de la gammagraf\u00eda cardiaca con 99mTc-DPD en la discriminaci\u00f3n del subtipo de amiloidosis cardiaca","volume":"65","author":"de Haro-del Moral","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.regg.2022.10.005_bib0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2017.06.011","article-title":"Novel pharmacotherapies for cardiac amyloidosis","volume":"180","author":"Alexander","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regg.2022.10.005_bib0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2020.09.011","article-title":"Efficacy of tafamidis in patients with hereditary and wild-type transthyretin amyloid cardiomyopathy","volume":"9","author":"Rapezzi","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.regg.2022.10.005_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"S2","key":"10.1016\/j.regg.2022.10.005_bib0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18087\/cardio.2390","article-title":"Transthyretin amyloidosis in a cohort of old and very old patients with chronic heart failure","author":"Poliakova","year":"2018","journal-title":"Kardiologiia"},{"key":"10.1016\/j.regg.2022.10.005_bib0275","first-page":"710","article-title":"Amyloidosis and 30-day outcomes among patients with heart failure","volume":"2","author":"Arora","year":"2020","journal-title":"JACC: CardioOncology"},{"key":"10.1016\/j.regg.2022.10.005_bib0280","doi-asserted-by":"crossref","first-page":"e004962","DOI":"10.1161\/CIRCHEARTFAILURE.118.004962","article-title":"Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial","volume":"11","author":"Solomon","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.regg.2022.10.005_bib0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2019.05.052","article-title":"Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction","volume":"74","author":"Tromp","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.regg.2022.10.005_bib0290","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3390\/jcm10153415","article-title":"Frailty in wild-type transthyretin cardiac amyloidosis: the tip of the iceberg","volume":"10","author":"Broussier","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.regg.2022.10.005_bib0295","doi-asserted-by":"crossref","first-page":"e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.regg.2022.10.005_bib0300","first-page":"2","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","author":"Cheng","year":"2020","journal-title":"JACC: CardioOncology"},{"key":"10.1016\/j.regg.2022.10.005_bib0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13506129.2019.1618261","article-title":"Trends and causes of hospitalizations in patients with amyloidosis","volume":"26","author":"Patil","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.regg.2022.10.005_bib0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","article-title":"Geographic disparities in reported US amyloidosis mortality from 1979 to 2015","volume":"3","author":"Alexander","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.regg.2022.10.005_bib0315","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.regg.2022.10.005_bib0320","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"}],"container-title":["Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X22001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211139X22001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:51:19Z","timestamp":1759323079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211139X22001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0211139X22001664"],"URL":"https:\/\/doi.org\/10.1016\/j.regg.2022.10.005","relation":{},"ISSN":["0211-139X"],"issn-type":[{"value":"0211-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of transthyretin cardiac amyloidosis in elderly patients diagnosed with heart failure","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regg.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEGG. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}